184 related articles for article (PubMed ID: 37296410)
1. Association between allostatic load and adverse outcomes among older patients with heart failure with preserved ejection fraction.
Hao B; Chen J; Cai Y; Li H; Zhu Z; Xu W; Liu H
BMC Geriatr; 2023 Jun; 23(1):360. PubMed ID: 37296410
[TBL] [Abstract][Full Text] [Related]
2. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
[TBL] [Abstract][Full Text] [Related]
4. Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
Pandey A; Golwala H; Sheng S; DeVore AD; Hernandez AF; Bhatt DL; Heidenreich PA; Yancy CW; de Lemos JA; Fonarow GC
JAMA Cardiol; 2017 Feb; 2(2):136-145. PubMed ID: 28030747
[TBL] [Abstract][Full Text] [Related]
5. Prognostic benefit of early diagnosis with exercise stress testing in heart failure with preserved ejection fraction.
Saito Y; Obokata M; Harada T; Kagami K; Wada N; Okumura Y; Ishii H
Eur J Prev Cardiol; 2023 Jul; 30(9):902-911. PubMed ID: 37094815
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of Framingham heart failure criteria in heart failure with preserved ejection fraction.
Löfström U; Hage C; Savarese G; Donal E; Daubert JC; Lund LH; Linde C
ESC Heart Fail; 2019 Aug; 6(4):830-839. PubMed ID: 31207140
[TBL] [Abstract][Full Text] [Related]
7. Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction.
Segar MW; Patel RB; Patel KV; Fudim M; DeVore AD; Martens P; Hedayati SS; Grodin JL; Tang WHW; Pandey A
JAMA Cardiol; 2021 Jan; 6(1):68-77. PubMed ID: 33206129
[TBL] [Abstract][Full Text] [Related]
8. Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction.
de Boer RA; Nayor M; deFilippi CR; Enserro D; Bhambhani V; Kizer JR; Blaha MJ; Brouwers FP; Cushman M; Lima JAC; Bahrami H; van der Harst P; Wang TJ; Gansevoort RT; Fox CS; Gaggin HK; Kop WJ; Liu K; Vasan RS; Psaty BM; Lee DS; Hillege HL; Bartz TM; Benjamin EJ; Chan C; Allison M; Gardin JM; Januzzi JL; Shah SJ; Levy D; Herrington DM; Larson MG; van Gilst WH; Gottdiener JS; Bertoni AG; Ho JE
JAMA Cardiol; 2018 Mar; 3(3):215-224. PubMed ID: 29322198
[TBL] [Abstract][Full Text] [Related]
9. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of Clinical Frailty Scale in patients with heart failure with preserved ejection fraction.
Sunaga A; Hikoso S; Yamada T; Yasumura Y; Uematsu M; Tamaki S; Abe H; Nakagawa Y; Higuchi Y; Fuji H; Mano T; Kurakami H; Yamada T; Kitamura T; Sato T; Oeun B; Kida H; Kojima T; Sotomi Y; Dohi T; Okada K; Suna S; Mizuno H; Nakatani D; Sakata Y;
ESC Heart Fail; 2021 Aug; 8(4):3316-3326. PubMed ID: 34151546
[TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure.
Gierula J; Cole CA; Drozd M; Lowry JE; Straw S; Slater TA; Paton MF; Byrom RJ; Garland E; Halliday G; Winsor S; Lyall GK; Birch K; McGinlay M; Sunley E; Grant PJ; Wessels DH; Ketiar EM; Witte KK; Cubbon RM; Kearney MT
ESC Heart Fail; 2022 Oct; 9(5):3254-3263. PubMed ID: 35790085
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population.
Chia YC; Kieneker LM; van Hassel G; Binnenmars SH; Nolte IM; van Zanden JJ; van der Meer P; Navis G; Voors AA; Bakker SJL; De Borst MH; Eisenga MF
J Am Heart Assoc; 2021 Jun; 10(11):e018549. PubMed ID: 33998283
[TBL] [Abstract][Full Text] [Related]
13. Heart rate and the risk of adverse outcomes in patients with heart failure with preserved ejection fraction.
O'Neal WT; Sandesara PB; Samman-Tahhan A; Kelli HM; Hammadah M; Soliman EZ
Eur J Prev Cardiol; 2017 Jul; 24(11):1212-1219. PubMed ID: 28482692
[TBL] [Abstract][Full Text] [Related]
14. Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study.
Takada T; Sakata Y; Miyata S; Takahashi J; Nochioka K; Miura M; Tadaki S; Shimokawa H;
Eur J Heart Fail; 2014 Mar; 16(3):309-16. PubMed ID: 24464774
[TBL] [Abstract][Full Text] [Related]
15. Impact of weight loss in patients with heart failure with preserved ejection fraction: results from the FLAGSHIP study.
Kamisaka K; Kamiya K; Iwatsu K; Iritani N; Imoto S; Adachi T; Iida Y; Yamada S;
ESC Heart Fail; 2021 Dec; 8(6):5293-5303. PubMed ID: 34599855
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
[TBL] [Abstract][Full Text] [Related]
17. Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype.
Fitzsimons S; Yeo TJ; Ling LH; Sim D; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Poppe K; Lund M; Devlin G; Troughton R; Lam CSP; Richards AM; Doughty RN
ESC Heart Fail; 2021 Dec; 8(6):4572-4583. PubMed ID: 34592056
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
[TBL] [Abstract][Full Text] [Related]
19. Atrial Fibrillation can adversely impact Heart Failure with Preserved Ejection Fraction by its association with Heart Failure Progression and Mortality: A Post-Hoc Propensity Score-Matched Analysis of the TOPCAT Americas Trial.
Saksena S; Slee A; Natale A; Lakkireddy DR; Shah D; Di Biase L; Lewalter T; Nagarakanti R; Santangeli P
Europace; 2023 May; 25(5):. PubMed ID: 37078691
[TBL] [Abstract][Full Text] [Related]
20. Arterial Stiffness and Risk of Overall Heart Failure, Heart Failure With Preserved Ejection Fraction, and Heart Failure With Reduced Ejection Fraction: The Health ABC Study (Health, Aging, and Body Composition).
Pandey A; Khan H; Newman AB; Lakatta EG; Forman DE; Butler J; Berry JD
Hypertension; 2017 Feb; 69(2):267-274. PubMed ID: 27993954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
